KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2016 - 2026)

Pacific Biosciences Of California has reported Other Non-Current Liabilities over the past 12 years, most recently at $546000.0 for Q4 2024.

  • For Q4 2024, Other Non-Current Liabilities fell 27.3% year-over-year to $546000.0; the TTM value through Dec 2024 reached $546000.0, down 27.3%, while the annual FY2024 figure was $546000.0, 27.3% down from the prior year.
  • Other Non-Current Liabilities for Q4 2024 was $546000.0 at Pacific Biosciences Of California, down from $751000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $200.0 million in Q3 2021 and troughed at $546000.0 in Q4 2024.
  • A 5-year average of $33.5 million and a median of $837000.0 in 2023 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 22327.39% in 2022 and later crashed 99.59% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $752000.0 in 2020, then surged by 361.57% to $3.5 million in 2021, then crashed by 62.55% to $1.3 million in 2022, then crashed by 42.23% to $751000.0 in 2023, then decreased by 27.3% to $546000.0 in 2024.
  • Business Quant data shows Other Non-Current Liabilities for PACB at $546000.0 in Q4 2024, $751000.0 in Q3 2024, and $751000.0 in Q2 2024.